Phil McEwan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Phil McEwan has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Klas Bergenheim
AstraZeneca, Mölndal, Sweden
10 shared publications H Bennett
5 shared publicationsM Evans
5 shared publicationsD Ayoubkhani
4 shared publicationsE Palaka
4 shared publicationsCj Currie
3 shared publications
Latest Publications
- 1 October 2017
- Published by Elsevier in Value in Health
- Vol. 20 (9) , A682
Quantifying The Relationship Between Hyperkalaemia And Outcomes In Patients With Heart Failure Or Chronic Kidney Disease
- 1 October 2017
- Published by Elsevier in Value in Health
- Vol. 20 (9) , A682
Quantifying The Relationship Between Hyperkalaemia And Outcomes In Patients With Heart Failure Or Chronic Kidney Disease
- 1 October 2017
- Published by Elsevier in Value in Health
- Vol. 20 (9) , A682
Development Of A Mortality Risk Prediction Tool For Patients With Heart Failure Or Chronic Kidney Disease At Risk Of Hyperkalaemia
- 1 October 2017
- Published by Elsevier in Value in Health
- Vol. 20 (9) , A682
Development Of A Mortality Risk Prediction Tool For Patients With Heart Failure Or Chronic Kidney Disease At Risk Of Hyperkalaemia
- 1 October 2017
- Published by Elsevier in Value in Health
- Vol. 20 (9) , A490
Impact of End-Stage Renal Disease on Health Economic Outcomes of Hyperkalaemia Management In Patients With Chronic Kidney Disease
- 1 October 2017
- Published by Elsevier in Value in Health
- Vol. 20 (9) , A490
Impact of End-Stage Renal Disease on Health Economic Outcomes of Hyperkalaemia Management In Patients With Chronic Kidney Disease
- 1 October 2017
- Published by Elsevier in Value in Health
- Vol. 20 (9) , A667
A Model To Predict Costs And Outcomes Associated With Hyperkalaemia In Patients With Chronic Kidney Disease Or Heart Failure
- 1 October 2017
- Published by Elsevier in Value in Health
- Vol. 20 (9) , A667
A Model To Predict Costs And Outcomes Associated With Hyperkalaemia In Patients With Chronic Kidney Disease Or Heart Failure
- 1 November 2015
- Published by Elsevier in Value in Health
- Vol. 18 (7) , A610-A611
Understanding The Inter-Relationship Between Improved Glycaemic Control, Hypoglycaemia and Weight Change Within A Type 1 Diabetic Population
- 1 November 2015
- Published by Elsevier in Value in Health
- Vol. 18 (7) , A610-A611
Understanding The Inter-Relationship Between Improved Glycaemic Control, Hypoglycaemia and Weight Change Within A Type 1 Diabetic Population
- 1 November 2015
- Published by Elsevier in Value in Health
- Vol. 18 (7) , A702
The Role of Patient Level Data In Assessing Health Economic Value: A Case Study Using Edge and The Core Diabetes Model
- 1 November 2015
- Published by Elsevier in Value in Health
- Vol. 18 (7) , A702
The Role of Patient Level Data In Assessing Health Economic Value: A Case Study Using Edge and The Core Diabetes Model
- 1 November 2014
- Published by Elsevier in Value in Health
- Vol. 17 (7) , A729-A730
Comparing the Event Prediction Capability of the Ukpds68 and Hong Kong Diabetes Risk Equations within A Type 2 Diabetes Simulation Model
- 1 November 2014
- Published by Elsevier in Value in Health
- Vol. 17 (7) , A729-A730
Comparing the Event Prediction Capability of the Ukpds68 and Hong Kong Diabetes Risk Equations within A Type 2 Diabetes Simulation Model
- Open Access
- 1 January 2012
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 10 (1) , 139
Characterizing the relationship between health utility and renal function after kidney transplantation in UK and US: a cross-sectional study
Chronic allograft nephropathy (CAN) occurs in a large share of transplant recipients and it is the leading cause of graft loss despite the introduction of new and effective immunosuppressants. The reduction in renal function secondary to immunologic and non-immunologic CAN leads to several complications, including anemia and calcium-phosphorus metabolism imbalance and may be associated to worsening Health-Related Quality of Life. We sought to evaluate the relationship between kidney function and Euro-Qol 5 Dimension Index (EQ-5Dindex) scores after kidney transplantation and evaluate whether cross-cultural differences exist between UK and US.
- 1 January 2012
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 10 (1) , 139
Open AccessCharacterizing the relationship between health utility and renal function after kidney transplantation in UK and US: a cross-sectional study
Chronic allograft nephropathy (CAN) occurs in a large share of transplant recipients and it is the leading cause of graft loss despite the introduction of new and effective immunosuppressants. The reduction in renal function secondary to immunologic and non-immunologic CAN leads to several complications, including anemia and calcium-phosphorus metabolism imbalance and may be associated to worsening Health-Related Quality of Life. We sought to evaluate the relationship between kidney function and Euro-Qol 5 Dimension Index (EQ-5Dindex) scores after kidney transplantation and evaluate whether cross-cultural differences exist between UK and US.
- 1 November 2011
- Published by Elsevier in Value in Health
- Vol. 14 (7) , A480
PDB47 Understanding the Implications of Incorporating the UKPDS Glycaemic Legacy Effect Into Evaluating the Cost-Effectiveness of Type 2 Diabetes Therapies
- 1 November 2011
- Published by Elsevier in Value in Health
- Vol. 14 (7) , A480
PDB47 Understanding the Implications of Incorporating the UKPDS Glycaemic Legacy Effect Into Evaluating the Cost-Effectiveness of Type 2 Diabetes Therapies